Bridgehead International Announces US West Coast Expansion

London 25^th July 2011...... Sasha Richardson, currently Bridgehead International Vice President, Europe, will be transferring to the US to take on the new challenge of establishing a West Coast presence for the company, whilst supporting the US management team as they continue to build the consultancy business in North America.

Sasha joined Bridgehead in 2007 has expertise in areas such as disease management, health economics, cost-benefit analysis, pricing, reimbursement and market access strategy.  She works with clients in the pharmaceutical, medical device and healthcare services sectors.   Prior to joining the company she had over 15 years operational and management experience in the healthcare / life sciences sector, having gained valuable international exposure in Canada (private & public), USA (private & life sciences), UK (St George’s Hospital, life sciences & consulting).

Sasha holds degrees in Biopsychology / Neurophysiology from the University of British Columbia and Physiotherapy from the University of Western Ontario.  She also has an MBA from HEC Paris / London Business School, with a concentration in finance and entrepreneurship.

Bridgehead International CEO, Timothy Fitzgerald commented; “Sasha’s move to the US comes at an exciting time for the company”. “As we continue to expand of our activities in North America, her expertises and experience, particularly in European market access and reimbursement, will be of real value to Bridgehead US and our clients”.  

Notes to editors:

About Bridgehead International

Bridgehead is a leading strategic healthcare consultancy group, providing a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain.

Bridgehead's mission is to work with commercial organisations, government agencies and the investment community to ensure that:

• Companies have the funding, structure and strategic focus to deliver high levels of innovation and financial return
• Patients have rapid and broad access to new innovative medicines, medical devices and diagnostic tools, particularly in areas of high unmet need.

With over 50 consultants and 60 associates in Europe, North America and Asia, Bridgehead provides a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience. 

Bridgehead is globally recognised for its expertise in:

• Market access strategy
• Pricing and reimbursement strategy
• Health economics and health technology assessment
• Opportunity evaluation
• Transaction support.

In 2007 and 2011, Bridgehead was honoured with The Queen’s Award for Enterprise, for outstanding achievement in international trade. The Queen’s Award for Enterprise is the highest honour that can be bestowed upon a UK company and is the UK’s top award for business performance.

In 2009, Bridgehead was voted UK Strategic Advisor of the Year – Healthcare, in the ACQ Finance Magazine’s Global Awards.

For more information about Bridgehead International, please see http://www.bridgehead.com

Contacts at Bridgehead International:

Jul 25, 2011